Nevro Corp NVRO Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-750

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-750

Price:

$169.80
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

750

Price:

$64.95
Jan 02, 2021 (filed on Jan 05, 2021)

Insider Name:

Rashid Kashif

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-1,365

Price:

$173.10
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Demane Michael F

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

160

Price:

--
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Weatherman Elizabeth H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

99

Price:

--
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Vale Brad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

90

Price:

--
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Fischer Frank M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

96

Price:

--
Dec 19, 2020 (filed on Dec 22, 2020)

Insider Name:

Grossman D Keith

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-4,998

Price:

$181.23
Dec 10, 2020 (filed on Dec 14, 2020)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-750

Price:

--

Filings by filing date

Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-750

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-750

Price:

$169.80
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

750

Price:

$64.95
Jan 02, 2021 (filed on Jan 05, 2021)

Insider Name:

Rashid Kashif

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-1,365

Price:

$173.10
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Demane Michael F

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

160

Price:

--
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Weatherman Elizabeth H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

99

Price:

--
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Vale Brad

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

90

Price:

--
Dec 31, 2020 (filed on Jan 05, 2021)

Insider Name:

Fischer Frank M

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

96

Price:

--
Dec 19, 2020 (filed on Dec 22, 2020)

Insider Name:

Grossman D Keith

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-4,998

Price:

$181.23
Dec 10, 2020 (filed on Dec 14, 2020)

Insider Name:

Pellegrini Niamh Louise

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-750

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	1800 Bridge Pkwy REDWOOD CITY CA 94065-1164
Tel:	1-650-4333247
Website:	https://www.nevro.com
IR:	See website

Key People

D.Keith Grossman Chairman of the Board, President, Chief Executive Officer	David Caraway Chief Medical Officer	Roderick MacLeod Chief Financial Officer
Lori Ciano Chief Human Resource Officer	Kashif Rashid Chief Compliance Officer, General Counsel, Corporate Secretary	Patrick Schmitz Vice President - Operations
Michael Carter Vice President - Global Sales	Julie D. Dewey Vice President - Investor Relations and Corporate Communications	Donald A. Middlebrook Vice President - Clinical, Regulatory and Quality
Christopher Christoforou Vice President - Research and Development

Business Overview

Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain. HF10 therapy enables patients to achieve sustained pain relief without paresthesia, thus enabling its patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia. HF10 therapy relies on consistent anatomical lead placement. As of December 31, 2016, it was investigating the use of HF10 therapy to address additional indications, such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. The Senza system is approved to create electrical impulses from 2 hertz (Hz) to 10,000 Hz.

Financial Overview

For the nine months ended 30 September 2020, NevroCorp revenues decreased 9% to $252.3M. Net loss decreased16% to $75.9M. Revenues reflect International segmentdecrease of 26% to $35.2M, United States segment decreaseof 5% to $217.1M. Lower net loss reflects Sales, generaland administrative decrease of 13% to $200.1M (expense),Research and Development decrease of 20% to $33.8M(expense).

Employees:	853 as of Dec 31, 2019

Reporting Currency:	U.S. Dollars
Enterprise value:	$5,945M as of Sep 30, 2020
Annual revenue (TTM):	$366.69M as of Sep 30, 2020
EBITDA (TTM):	-$63.01M as of Sep 30, 2020
Net annual income (TTM):	-$89.68M as of Sep 30, 2020
Free cash flow (TTM):	-$28.96M as of Sep 30, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	34,428,772 as of Oct 30, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Nevro Corp (N:NVRO)